 | • レポートコード：GIR201111429 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、グルカゴン様ペプチド-2（GLP-2）アゴニストの世界市場を調査対象にし、グルカゴン様ペプチド-2（GLP-2）アゴニストの市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（ガテックス、リ ベス ティブ）、用途別分析（病院、薬局、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Takeda Pharmaceuticals ・メーカー別販売量、売上、市場シェア ・グルカゴン様ペプチド-2（GLP-2）アゴニストの地域別市場分析 ・グルカゴン様ペプチド-2（GLP-2）アゴニストの北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・グルカゴン様ペプチド-2（GLP-2）アゴニストのヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・グルカゴン様ペプチド-2（GLP-2）アゴニストのアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・グルカゴン様ペプチド-2（GLP-2）アゴニストの南米市場規模2015-2020：ブラジル、アルゼンチンなど ・グルカゴン様ペプチド-2（GLP-2）アゴニストの中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・グルカゴン様ペプチド-2（GLP-2）アゴニストの種類別市場規模2015-2020：ガテックス、リ ベス ティブ ・グルカゴン様ペプチド-2（GLP-2）アゴニストの用途別市場規模2015-2020：病院、薬局、その他 ・グルカゴン様ペプチド-2（GLP-2）アゴニストの世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Glucagon-like Peptide-2 (GLP-2) Agonist market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Glucagon-like Peptide-2 (GLP-2) Agonist market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Glucagon-like Peptide-2 (GLP-2) Agonist market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Glucagon-like Peptide-2 (GLP-2) Agonist market has been segmented into
Gattex
Revestive
By Application, Glucagon-like Peptide-2 (GLP-2) Agonist has been segmented into:
Hospital
Pharmacy
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Glucagon-like Peptide-2 (GLP-2) Agonist market presented in the report. This section sheds light on the sales growth of different regional and country-level Glucagon-like Peptide-2 (GLP-2) Agonist markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Glucagon-like Peptide-2 (GLP-2) Agonist market.
The report offers in-depth assessment of the growth and other aspects of the Glucagon-like Peptide-2 (GLP-2) Agonist market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Glucagon-like Peptide-2 (GLP-2) Agonist Market Share Analysis
Glucagon-like Peptide-2 (GLP-2) Agonist competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Glucagon-like Peptide-2 (GLP-2) Agonist sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Glucagon-like Peptide-2 (GLP-2) Agonist sales, revenue and market share for each player covered in this report.
The major players covered in Glucagon-like Peptide-2 (GLP-2) Agonist are:
Takeda Pharmaceuticals
Among other players domestic and global, Glucagon-like Peptide-2 (GLP-2) Agonist market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Glucagon-like Peptide-2 (GLP-2) Agonist product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Glucagon-like Peptide-2 (GLP-2) Agonist, with price, sales, revenue and global market share of Glucagon-like Peptide-2 (GLP-2) Agonist in 2018 and 2019.
Chapter 3, the Glucagon-like Peptide-2 (GLP-2) Agonist competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Glucagon-like Peptide-2 (GLP-2) Agonist breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Glucagon-like Peptide-2 (GLP-2) Agonist market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Glucagon-like Peptide-2 (GLP-2) Agonist sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Glucagon-like Peptide-2 (GLP-2) Agonist Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Gattex
1.2.3 Revestive
1.3 Market Analysis by Application
1.3.1 Overview: Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Overview of Global Glucagon-like Peptide-2 (GLP-2) Agonist Market
1.4.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Takeda Pharmaceuticals
2.1.1 Takeda Pharmaceuticals Details
2.1.2 Takeda Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Takeda Pharmaceuticals SWOT Analysis
2.1.4 Takeda Pharmaceuticals Product and Services
2.1.5 Takeda Pharmaceuticals Glucagon-like Peptide-2 (GLP-2) Agonist Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Glucagon-like Peptide-2 (GLP-2) Agonist Manufacturer Market Share in 2019
3.3.2 Top 6 Glucagon-like Peptide-2 (GLP-2) Agonist Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales, Revenue and Market Share by Regions
4.1.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Market Share by Regions (2015-2020)
4.1.2 Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue and Market Share by Regions (2015-2020)
4.2 North America Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2015-2020)
4.3 Europe Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2015-2020)
4.5 South America Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Glucagon-like Peptide-2 (GLP-2) Agonist Sales, Revenue and Market Share by Country
5.1.1 North America Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Market Share by Country (2015-2020)
5.1.2 North America Glucagon-like Peptide-2 (GLP-2) Agonist Revenue and Market Share by Country (2015-2020)
5.2 United States Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2015-2020)
5.3 Canada Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2015-2020)
5.4 Mexico Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Glucagon-like Peptide-2 (GLP-2) Agonist Sales, Revenue and Market Share by Country
6.1.1 Europe Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Market Share by Country (2015-2020)
6.1.2 Europe Glucagon-like Peptide-2 (GLP-2) Agonist Revenue and Market Share by Country (2015-2020)
6.2 Germany Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2015-2020)
6.3 UK Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2015-2020)
6.4 France Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2015-2020)
6.5 Russia Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2015-2020)
6.6 Italy Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Glucagon-like Peptide-2 (GLP-2) Agonist Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Glucagon-like Peptide-2 (GLP-2) Agonist Revenue and Market Share by Regions (2015-2020)
7.2 China Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2015-2020)
7.3 Japan Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2015-2020)
7.4 Korea Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2015-2020)
7.5 India Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2015-2020)
7.7 Australia Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Glucagon-like Peptide-2 (GLP-2) Agonist Sales, Revenue and Market Share by Country
8.1.1 South America Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Market Share by Country (2015-2020)
8.1.2 South America Glucagon-like Peptide-2 (GLP-2) Agonist Revenue and Market Share by Country (2015-2020)
8.2 Brazil Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2015-2020)
8.3 Argentina Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Glucagon-like Peptide-2 (GLP-2) Agonist Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Glucagon-like Peptide-2 (GLP-2) Agonist Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2015-2020)
9.3 Turkey Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2015-2020)
9.4 Egypt Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2015-2020)
9.5 South Africa Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Market Share by Type (2015-2020)
10.2 Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue and Market Share by Type (2015-2020)
10.3 Global Glucagon-like Peptide-2 (GLP-2) Agonist Price by Type (2015-2020)
11 Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Segment by Application
11.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Application (2015-2020)
11.2 Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share by Application (2015-2020)
11.3 Global Glucagon-like Peptide-2 (GLP-2) Agonist Price by Application (2015-2020)
12 Market Forecast
12.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales, Revenue and Growth Rate (2021-2025)
12.2 Glucagon-like Peptide-2 (GLP-2) Agonist Market Forecast by Regions (2021-2025)
12.2.1 North America Glucagon-like Peptide-2 (GLP-2) Agonist Market Forecast (2021-2025)
12.2.2 Europe Glucagon-like Peptide-2 (GLP-2) Agonist Market Forecast (2021-2025)
12.2.3 Asia-Pacific Glucagon-like Peptide-2 (GLP-2) Agonist Market Forecast (2021-2025)
12.2.4 South America Glucagon-like Peptide-2 (GLP-2) Agonist Market Forecast (2021-2025)
12.2.5 Middle East & Africa Glucagon-like Peptide-2 (GLP-2) Agonist Market Forecast (2021-2025)
12.3 Glucagon-like Peptide-2 (GLP-2) Agonist Market Forecast by Type (2021-2025)
12.3.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Forecast by Type (2021-2025)
12.3.2 Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Share Forecast by Type (2021-2025)
12.4 Glucagon-like Peptide-2 (GLP-2) Agonist Market Forecast by Application (2021-2025)
12.4.1 Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Forecast by Application (2021-2025)
12.4.2 Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Glucagon-like Peptide-2 (GLP-2) Agonist by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Takeda Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 8. Takeda Pharmaceuticals Glucagon-like Peptide-2 (GLP-2) Agonist Major Business
Table 9. Takeda Pharmaceuticals Glucagon-like Peptide-2 (GLP-2) Agonist Total Revenue (USD Million) (2017-2018)
Table 10. Takeda Pharmaceuticals SWOT Analysis
Table 11. Takeda Pharmaceuticals Glucagon-like Peptide-2 (GLP-2) Agonist Product and Services
Table 12. Takeda Pharmaceuticals Glucagon-like Peptide-2 (GLP-2) Agonist Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Manufacturer (2018-2019) (K Units)
Table 14. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue by Manufacturer (2018-2019) (USD Million)
Table 15. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Regions (2015-2020) (K Units)
Table 16. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Regions (2015-2020)
Table 17. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue by Regions (2015-2020) (USD Million)
Table 18. North America Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Countries (2015-2020) (K Units)
Table 19. North America Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Countries (2015-2020)
Table 20. North America Glucagon-like Peptide-2 (GLP-2) Agonist Revenue by Countries (2015-2020) (USD Million)
Table 21. North America Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share by Countries (2015-2020)
Table 22. Europe Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Countries (2015-2020) (K Units)
Table 23. Europe Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Countries (2015-2020)
Table 24. Europe Glucagon-like Peptide-2 (GLP-2) Agonist Revenue by Countries (2015-2020) (USD Million)
Table 25. Asia-Pacific Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Regions (2015-2020) (K Units)
Table 26. Asia-Pacific Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Regions (2015-2020)
Table 27. Asia-Pacific Glucagon-like Peptide-2 (GLP-2) Agonist Revenue by Regions (2015-2020) (USD Million)
Table 28. South America Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Countries (2015-2020) (K Units)
Table 29. South America Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Countries (2015-2020)
Table 30. South America Glucagon-like Peptide-2 (GLP-2) Agonist Revenue by Countries (2015-2020) (USD Million)
Table 31. South America Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share by Countries (2015-2020)
Table 32. Middle East & Africa Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Countries (2015-2020) (K Units)
Table 33. Middle East & Africa Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Countries (2015-2020)
Table 34. Middle East & Africa Glucagon-like Peptide-2 (GLP-2) Agonist Revenue by Countries (2015-2020) (USD Million)
Table 35. Middle East & Africa Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share by Countries (2015-2020)
Table 36. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Type (2015-2020) (K Units)
Table 37. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Share by Type (2015-2020)
Table 38. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue by Type (2015-2020) (USD Million)
Table 39. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Share by Type (2015-2020)
Table 40. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales by Application (2015-2020) (K Units)
Table 41. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Share by Application (2015-2020)
Table 42. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Forecast by Regions (2021-2025) (K Units)
Table 43. Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Share Forecast by Regions (2021-2025)
Table 44. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Forecast by Type (2021-2025) (K Units)
Table 45. Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Share Forecast by Type (2021-2025)
Table 46. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Forecast by Application (2021-2025)
Table 47. Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Share Forecast by Application (2021-2025)
Table 48. Direct Channel Pros & Cons
Table 49. Indirect Channel Pros & Cons
Table 50. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Glucagon-like Peptide-2 (GLP-2) Agonist Picture
Figure 2. Global Sales Market Share of Glucagon-like Peptide-2 (GLP-2) Agonist by Type in 2019
Figure 3. Gattex Picture
Figure 4. Revestive Picture
Figure 5. Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Application in 2018
Figure 6. Hospital Picture
Figure 7. Pharmacy Picture
Figure 8. Other Picture
Figure 9. Global Glucagon-like Peptide-2 (GLP-2) Agonist Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Glucagon-like Peptide-2 (GLP-2) Agonist Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Glucagon-like Peptide-2 (GLP-2) Agonist Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Glucagon-like Peptide-2 (GLP-2) Agonist Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Glucagon-like Peptide-2 (GLP-2) Agonist Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Glucagon-like Peptide-2 (GLP-2) Agonist Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Glucagon-like Peptide-2 (GLP-2) Agonist Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Glucagon-like Peptide-2 (GLP-2) Agonist Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Glucagon-like Peptide-2 (GLP-2) Agonist Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Glucagon-like Peptide-2 (GLP-2) Agonist Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Glucagon-like Peptide-2 (GLP-2) Agonist Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Glucagon-like Peptide-2 (GLP-2) Agonist Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Glucagon-like Peptide-2 (GLP-2) Agonist Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Glucagon-like Peptide-2 (GLP-2) Agonist Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Glucagon-like Peptide-2 (GLP-2) Agonist Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Glucagon-like Peptide-2 (GLP-2) Agonist Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Glucagon-like Peptide-2 (GLP-2) Agonist Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Glucagon-like Peptide-2 (GLP-2) Agonist Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Glucagon-like Peptide-2 (GLP-2) Agonist Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Glucagon-like Peptide-2 (GLP-2) Agonist Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Manufacturer in 2019
Figure 30. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Glucagon-like Peptide-2 (GLP-2) Agonist Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Glucagon-like Peptide-2 (GLP-2) Agonist Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2015-2020) (K Units)
Figure 35. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share by Regions (2015-2020)
Figure 37. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share by Regions in 2018
Figure 38. North America Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2015-2020)
Figure 39. Europe Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2015-2020)
Figure 41. South America Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2015-2020)
Figure 43. North America Glucagon-like Peptide-2 (GLP-2) Agonist Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Countries (2015-2020)
Figure 45. North America Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Countries in 2018
Figure 46. North America Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share by Countries in 2018
Figure 48. United States Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Canada Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Mexico Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Europe Glucagon-like Peptide-2 (GLP-2) Agonist Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share by Countries in 2019
Figure 54. Germany Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2015-2020) (K Units)
Figure 55. UK Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2015-2020) (K Units)
Figure 56. France Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Russia Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Italy Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Asia-Pacific Glucagon-like Peptide-2 (GLP-2) Agonist Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share by Regions 2019
Figure 62. China Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Japan Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Korea Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2015-2020) (K Units)
Figure 65. India Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Southeast Asia Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2015-2020) (K Units)
Figure 67. South America Glucagon-like Peptide-2 (GLP-2) Agonist Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Countries in 2019
Figure 69. South America Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share by Countries in 2019
Figure 70. Brazil Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Middle East and Africa Glucagon-like Peptide-2 (GLP-2) Agonist Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Glucagon-like Peptide-2 (GLP-2) Agonist Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Glucagon-like Peptide-2 (GLP-2) Agonist Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Egypt Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Turkey Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2015-2020) (K Units)
Figure 79. South Africa Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Global Glucagon-like Peptide-2 (GLP-2) Agonist Sales and Growth Rate (2021-2025) (K Units)
Figure 81. Global Glucagon-like Peptide-2 (GLP-2) Agonist Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Glucagon-like Peptide-2 (GLP-2) Agonist Market Forecast (2021-2025) (K Units)
Figure 83. Europe Sales Glucagon-like Peptide-2 (GLP-2) Agonist Market Forecast (2021-2025) (K Units)
Figure 84. Asia-Pacific Sales Glucagon-like Peptide-2 (GLP-2) Agonist Market Forecast (2021-2025) (K Units)
Figure 85. South America Sales Glucagon-like Peptide-2 (GLP-2) Agonist Market Forecast (2021-2025) (K Units)
Figure 86. Middle East & Africa Sales Glucagon-like Peptide-2 (GLP-2) Agonist Market Forecast (2021-2025) (K Units)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
グルカゴン様ペプチド-1（GLP-1）アゴニストの世界市場 2020年 Market Overview The Glucagon Like Peptide-1 (GLP-1) Agonists market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value …- グルカゴン様ペプチド2受容体の世界市場 2020年 Market Overview The global Glucagon Like Peptide 2 Receptor market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Glucagon Lik…
- グルカゴンの世界市場 2020年 Market Overview The Glucagon market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…
- ゴナドトロピン放出ホルモンアゴニストの世界市場 2020年 Market Overview The global Gonadotropin-releasing Hormone Agonist market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Gonado…
- ゴナドトロピン放出ホルモン作動薬の世界市場 2020年 Market Overview The global Gonadotropin-releasing Hormone Agonist Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The …